Paid Clinical Trials Paid Clinical Trials > Browse Categories > Medical Conditions > AIDS/HIV > Louisiana

Louisiana

Louisiana

All Categories Medical Conditions » AIDS/HIV » Louisiana


  • Trial of Probiotics to Lower Microbial Translocation and Immune Activation in HIV-Infected Adolescents

    Condition:   HIV Infection
    Interventions:   Dietary Supplement: Probiotics;   Dietary Supplement: Placebo
    Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
    Not yet recruiting - verified November 2011
  • Comparative Trial Of Maraviroc Versus Emtricitabine/Tenofovir Both With Darunavir/Ritonavir In Antiretroviral-Naive Patients Infected With Ccr5 Tropic HIV 1

    Condition:   HIV-1
    Interventions:   Drug: Maraviroc;   Drug: Emtricitabine/tenofovir
    Sponsors:   ViiV Healthcare;   ViiV Healthcare;   Pfizer
    Recruiting - verified May 2012
  • Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

    Condition:   HIV Disease
    Interventions:   Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified May 2012
  • A Study to Assess Dolutegravir in HIV-infected Subjects With Treatment Failure on an Integrase Inhibitor Containing Regimen.

    Condition:   Infection, Human Immunodeficiency Virus
    Intervention:   Drug: dolutegravir
    Sponsors:   ViiV Healthcare;   ViiV Healthcare;   Shionogi;   GlaxoSmithKline
    Recruiting - verified February 2012
  • Enhancement of Connect to Protect® (C2P)

    Condition:   HIV Infection
    Intervention:   Behavioral: Community Mobilization
    Sponsors:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH)
    Recruiting - verified October 2011
  • Safety of and Immune Response to GSK1349572 in HIV-1 Infected Infants, Children, and Adolescents

    Condition:   HIV Infections
    Interventions:   Drug: GSK1349572 tablet formulation;   Drug: GSK1349572 pediatric formulation
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified May 2012
  • A Trial of Lopinavir/Ritonavir Dosed According to the Who Pediatric Weight Band Dosing Guidelines

    Condition:   HIV Infection
    Intervention:   Drug: Lopinavir/ritonavir (LPV/r)
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   Abbott
    Recruiting - verified May 2012
  • Long-Term Outcomes in HIV-Infected Infants, Children, and Adolescents

    Condition:   HIV Infections
    Intervention:  
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified May 2012
  • Examining Benefits of HAART Continuation in Postpartum Mothers

    Condition:   HIV Infections
    Intervention:   Drug: Highly active antiretroviral therapy (HAART)
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified May 2012
  • Strategic Timing of Antiretroviral Treatment

    Condition:   HIV Infection
    Intervention:   Drug: All licensed antiretroviral medications
    Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   University of Minnesota - Clinical and Translational Science Institute;   National Institute of Allergy and Infectious Diseases (NIAID);   Copenhagen HIV Programme (CHIP) -- Copenhagen, Denmark;   Medical Research Council (MRC) Clinical Trials Unit -- London, United Kingdom;   Kirby Institute;   The Institute for Clinical Research at the Veterans Affairs Medical Center -- Washington, D.C., USA;   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS);   German Federal Ministry of Education and Research;   NEAT - European AIDS Treatment Network;   National Health and Medical Research Council, Australia;   National Institutes of Health Clinical Center (CC);   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI);   National Institute of Mental Health (NIMH);   National Institute of Neurological Disorders and Stroke (NINDS);   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   Abbott;   Bristol-Myers Squibb;   Gilead Sciences;   GlaxoSmithKline;   Merck;   Tibotec Pharmaceutical Limited
    Recruiting - verified April 2012
  • HIV Prevention Program for African American Teen Males

    Conditions:   HIV Infections;   Sexually Transmitted Infections
    Interventions:   Behavioral: Male Sexual Health Program;   Behavioral: Focus on the Future Program
    Sponsors:   University of Kentucky;   University of Kentucky;   Louisiana State University Health Sciences Center in New Orleans;   Carolinas Healthcare System
    Recruiting - verified August 2011
  • TMC278-TiDP38-C213 (PAINT): An Open Label Trial to Evaluate the Pharmacokinetics, Safety, Tolerability and Antiviral Efficacy of TMC278 in Antiretroviral Naive HIV-1 Infected Adolescents

    Conditions:   HIV Infections;   HIV-1
    Intervention:   Drug: TMC278
    Sponsors:   Tibotec Pharmaceuticals, Ireland;   Tibotec Pharmaceuticals, Ireland
    Recruiting - verified February 2012
  • Prospective Observational Epidemiologic Study of Maraviroc's Safety

    Condition:   Human Immunodeficiency Virus
    Interventions:   Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
    Sponsors:   ViiV Healthcare;   ViiV Healthcare;   Pfizer
    Recruiting - verified May 2012
  • Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia

    Conditions:   HIV Infections;   Hyperlipidemia
    Intervention:   Drug: Atorvastatin
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified May 2012
  • Safety and Effectiveness of Raltegravir (MK-0518) in Treatment-Experienced, HIV-Infected Children and Adolescents

    Condition:   HIV Infections
    Interventions:   Drug: Raltegravir (MK-0518);   Drug: Raltegravir (MK-0518);   Drug: Raltegravir (MK-0518)
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified April 2012
  • An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

    Condition:   HIV Infection
    Intervention:   Drug: Efavirenz
    Sponsors:   Bristol-Myers Squibb;   Bristol-Myers Squibb
    Available - verified January 2012
  • Emergency Use Program for HTE HIV+ Patients Who Need Tipranavir Treatment

    Condition:   HIV Infections
    Intervention:   Drug: Tipranavir
    Sponsors:   Boehringer Ingelheim Pharmaceuticals;   Boehringer Ingelheim Pharmaceuticals
    Available - verified May 2012
  • Pharmacokinetic Study of Anti-HIV Drugs During Pregnancy

    Condition:   HIV Infections
    Intervention:   Drug: Current ARV medications
    Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified April 2012
  • Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

    Conditions:   HIV Infections;   Pregnancy Complications, Infectious
    Intervention:   Behavioral: Adherence assessment
    Sponsors:   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   International Maternal Pediatric Adolescent AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified May 2012
  • Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

    Condition:   HIV Infections
    Intervention:  
    Sponsors:   AIDS Clinical Trials Group;   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting - verified January 2012

Main Menu
Clinical Trial Categories
Clinical Trial Locations